Literature DB >> 9003048

Amygdala kindling modifies extracellular opioid peptide content in rat hippocampus measured by microdialysis.

L L Rocha1, C J Evans, N T Maidment.   

Abstract

Opioid peptide release in the hippocampus was shown to be increased immediately following amygdala kindling stimulation in freely moving rats using microdialysis combined with a universal opioid peptide radioimmunoassay (RIA). Extracellular opioid peptide levels were elevated (55% above basal levels) within the first 10 min after electrical stimulation-induced partial seizures in previously nonkindled animals. Fully kindled rats showed lower extracellular opioid peptide levels (40% reduction) during the interictal period [16 +/- 2.1 days (mean +/- SEM) after the last stage V seizure], in comparison with values obtained from the sham-kindled group under basal conditions. However, opioid peptide release in fully kindled rats increased above 152% of interictal levels within the first 20 min after onset of fully kindled seizures, attaining peak levels equal to that of the partial kindled group and returning to prestimulation conditions 40-60 min following the ictal events. The majority of the immunoreactive material recovered from the hippocampus within the first 20 min following partial and generalized kindled seizures coeluted with dynorphin-A (1-6), dynorphin-A (1-8), and Leu-enkephalin by HPLC/RIA analysis. It is proposed that the enhanced opioid peptide release in hippocampus induced by amygdala kindling stimulation might be associated with either enhanced excitability or seizure suppression as seizure susceptibility fluctuates. The reduced interictal opioid peptide levels may also underlie some interictal behavioral disturbances.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003048     DOI: 10.1046/j.1471-4159.1997.68020616.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Levels of vancomycin in the cerebral interstitial fluid after severe head injury.

Authors:  Anselmo Caricato; Mariano Pennisi; Aldo Mancino; Gianluca Vigna; Claudio Sandroni; Andrea Arcangeli; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2006-01-24       Impact factor: 17.440

Review 2.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

3.  Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy.

Authors:  H Potschka; E Friderichs; W Löscher
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Activation of κ opioid receptors increases intrinsic excitability of dentate gyrus granule cells.

Authors:  Carmel M McDermott; Laura A Schrader
Journal:  J Physiol       Date:  2011-05-23       Impact factor: 5.182

5.  On-Column Dimethylation with Capillary Liquid Chromatography-Tandem Mass Spectrometry for Online Determination of Neuropeptides in Rat Brain Microdialysate.

Authors:  Rachael E Wilson; Andrea Jaquins-Gerstl; Stephen G Weber
Journal:  Anal Chem       Date:  2018-03-22       Impact factor: 6.986

6.  Region-specific changes in prodynorphin mRNA and ir-dynorphin A levels after kindled seizures.

Authors:  P Romualdi; G Bregola; A Donatini; A Capobianco; M Simonato
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

7.  Stage-specific modulation of neprilysin and aminopeptidase N in the limbic system during kindling progression.

Authors:  Patricia de Gortari; Miguel Angel Vargas; Adrián Martínez; Arlene I García-Vázquez; Rosa María Uribe; Lucía Chávez-Gutiérrez; Víctor Magdaleno; Guy Boileau; Jean-Louis Charlí; Patricia Joseph-Bravo
Journal:  J Mol Neurosci       Date:  2007-04-17       Impact factor: 3.444

Review 8.  Review of recent advances in analytical techniques for the determination of neurotransmitters.

Authors:  Maura Perry; Qiang Li; Robert T Kennedy
Journal:  Anal Chim Acta       Date:  2009-09-01       Impact factor: 6.558

Review 9.  The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential.

Authors:  Johannes Burtscher; Christoph Schwarzer
Journal:  Front Mol Neurosci       Date:  2017-08-07       Impact factor: 5.639

Review 10.  Neuropeptides as targets for the development of anticonvulsant drugs.

Authors:  Elke Clynen; Ann Swijsen; Marjolein Raijmakers; Govert Hoogland; Jean-Michel Rigo
Journal:  Mol Neurobiol       Date:  2014-04-06       Impact factor: 5.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.